European Registry Study on Lymphatic Interventions
Studying Congenital chylothorax
Last synced from ClinicalTrials.gov
Key facts
- Sponsor
- Rigshospitalet, Denmark
- Principal Investigator
- Vibeke E Hjortdal, ProfessorRigshospitalet, Denmark
- Intervention
- Lymphatic intervention(procedure)
- Enrollment
- 500 enrolled
- Eligibility
- All sexes
- Timeline
- 2026 – 2030
Study locations (1)
- Rigshospitalet, Copenhagen University Hospital, Copenhagen, Denmark
Collaborators
UZ Leuven, Leuven, Belgium · UCL Bruxelles · Lund University Hospital · University Hospital Schleswig-Holstein · University Hospital, Aachen · Deutsches Herzzentrum Muenchen · Universitätsklinikum Erlangen, Erlangen, Bayern, Germany · UZ Gent, Belgium · Hospital for Children and Adolescents, University of Helsinki · Hospital Universitari Vall d'hebron Barcelona, Spain · Children's University Hospital, Ireland · Evelina London Children's Hospital · Guy's and St Thomas' NHS Foundation Trust · Bambin Gesù Hospital IRCCS, Rome, Italy
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT07131293 on ClinicalTrials.govOther trials for Congenital chylothorax
Additional recruiting or active studies for the same condition.